Similar articles

• [Metabolism of phenylbutazone in the liver (author's transl)].

  González Macías J, De Castro del Pozo S. González Macías J, et al. Med Klin. 1976 Sep 3;71(36):1434-8. Med Klin. 1976. PMID: 958107 German.
• [Drug dosing in chronic hepatic disease (author's transl)].

  Gugler R, Eichelbaum M. Gugler R, et al. Leber Magen Darm. 1981 Apr;11(2):81-7. Leber Magen Darm. 1981. PMID: 7015045 Review. German.
• [Side effects of drugs--predictable hazards for patients with liver disease].

  Baumgarten R. Baumgarten R. Z Arztl Fortbild (Jena). 1983;77(9):373-5. Z Arztl Fortbild (Jena). 1983. PMID: 6880279 German. No abstract available.
• [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].

  Magnenat P. Magnenat P. Ther Umsch. 1979 May;36(5):432-8. Ther Umsch. 1979. PMID: 451956 French. No abstract available.
• [Drug metabolism in newborn infant (author's transl)].

  Abucewicz A, Szyszka K. Abucewicz A, et al. Przegl Lek. 1973;30(7):596-9. Przegl Lek. 1973. PMID: 4583911 Review. Polish. No abstract available.